Juan Pablo Frias - 31 Aug 2023 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role: Chief Medical Officer
Signature: /s/ Franco Valle as Attorney-in-Fact for Juan Pablo Frias
Issuer symbol: BMEA
Transactions as of: 31 Aug 2023
Net transactions value: $0
Form type: 4
Filing time: 01 Sep 2023, 17:10:37 UTC
Next filing: 18 Jan 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMEA	Stock Option (Right to Buy)	Award	$0	+300,000		$0.000000	300,000	31 Aug 2023	Common Stock	300,000	$16.87	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable at the end of the third month following August 31, 2023 and one-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable quarterly thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Content

One-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable at the end of the third month following August 31, 2023 and one-sixteenth (1/16th) of the total number of shares subject to the stock option shall vest and become exercisable quarterly thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.